Medians for second-trimester maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups

Clinical Chemistry

Volumn 43, Issue 2, 1997, Pages 333-337

  Benn, Peter A ^a   Clive, Jonathan M ^b   Collins, Roxanne ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Lowell P Weicker Clin Res Center   (United States)

Author keywords

Down syndrome; maternal serum screening; open neural tube defects; triple marker testing

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOWN SYNDROME; ESTRIOL BLOOD LEVEL; ETHNIC GROUP; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEURAL TUBE DEFECT; PRENATAL SCREENING; RACE DIFFERENCE; SECOND TRIMESTER PREGNANCY;

EID: 0031030569     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.2.333     Document Type: Article

References (18)

1. Knight GJ, Palomaki GE. Maternal alpha-fetoprotein and the detection of open neural tube defects. In: Elias S, Simpson JL, eds. Maternal serum screening for fetal genetic disorders. New York: Churchill Livingstone, 1992:41-58.
2. Burton BK. Unexplained elevated maternal serum alpha-fetoprotein and adverse perinatal outcome. In: Elias S, Simpson JL, eds. Maternal serum screening for fetal genetic disorders. New York: Churchill Livingstone, 1992:109-19.
3. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7.
4. Canick JA, Palomaki GE, Osathanondh R. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990;10: 546-8.
5. Crandall BF, Lebherz TB, Schroth PC, Matsumoto M. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 1983;29:531-3.
6. Johnson AM. Racial differences in maternal serum alpha-fetoprotein screening. In: Mizejewski GJ, Porter IH, eds. Alpha-fetoprotein and congenital disorders. New York: Academic Press, 1985:183-96.
7. Baumgarten A. Racial difference and biological significance of maternal serum alpha-fetoprotein. Lancet 1986;ii:573.
8. Macri JN, Kasturi RV, Hu MG, Krantz DA, Douros TJ, Sajda P, Cook EJ. Maternal serum α-fetoprotein screening. III. Pitfalls in evaluating black gravid women. Am J Obstet Gynecol 1987;157:820-2.
9. Simpson JL, Elias S, Morgan CD, Shulman L, Umstot E, Anderson RN. Second trimester maternal serum human chorionic gonadotropin and unconjugated oestriol levels in blacks and whites. Lancet 1990;335:459-60.
10. Muller F, Boue A. A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome. Prenat Diagn 1990;10:389-98.
11. Canick JA, Panizza DS, Palomaki GE. Prenatal screening for Down syndrome using AFP, uE3 and hCG: effect of maternal race, insulin-dependent diabetes and twin pregnancy. Am J Hum Genet 1990;47:A270.
12. Burton BK, Nieb B. Effect of maternal race and weight (wt) on hCG and uE3 levels in the mid-trimester. Am J Hum Genet 1991;49: A212.
13. Bogart MH, Jones OW, Felder RA, et al. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991;165:663-7.
14. Benn PA, Horne D, Briganti S, Greenstein RM. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome. Am J Obstet Gynecol 1995;173:496-501.
15. Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981;27: 493-501.
16. Knight GJ, Palomaki GE, Haddow JE. Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome. Clin Obstet Gynecol 1988;31:306-27.
17. Palomaki GE, Panizza DS, Canick JA. Screening for Down syndrome using AFP, uE3, and hCG: effect of maternal weight. Am J Hum Genet 1990;47:A282.
18. Wald N, Cuckle H, Borcham J. Effect of estimating gestational age by ultrasound cephalometry on the specificity of α-fetoprotein screening for open neural-tube defects. Br J Obstet Gynaecol 1982;89:1050-3.